Moderna Inc. stock: October 24 melanoma data ahead of Xetra open
Published on 10/21/2026 at 08:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSMelanoma data date set
- Yahoo Finance reported the upcoming Moderna and Merck melanoma presentation on October 20, 2026.
- Late-stage data are scheduled for October 24, 2026, at the European Society for Medical Oncology congress.
- Moderna Inc. stock trades pre-market at EUR 216.08 at 7:59 a.m. CEST at Lang & Schwarz on October 21, 2026.
Yahoo Finance reported on October 20, 2026, that Moderna and Merck will present late-stage melanoma data on October 24, 2026. Moderna Inc. stock trades pre-market at EUR 216.08 at 7:59 a.m. CEST at Lang & Schwarz on October 21, 2026.
Melanoma data scheduled for October 24
The presentation is scheduled for the European Society for Medical Oncology congress in Madrid, with a Moderna investor webcast to follow, according to Yahoo Finance. The report said the study tests intismeran autogene plus Keytruda against Keytruda alone after surgery.
Ahead of the Xetra open
The stock is quoted at Lang & Schwarz in pre-market trading on October 21, 2026. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Moderna Inc. stock.
Moderna and its mRNA medicines
Moderna develops mRNA medicines that prompt the body to create tools intended to treat or prevent disease, according to Moderna. The October 24 presentation and webcast are the next cited company-related events. Market context: Market report Nasdaq Composite.
